The Plan to End HIV For Good: The Truvada Revolution (Part 1/3)
Published June 3, 2015
This video has 526K views and 2.87K likes, ranking #3,879,787 globally among tracked YouTube videos by view count.
At a glance
Views
526,851
Likes
2,869
Comments
1,015
Performance vs. channel
Outlier score
Engagement rate
More features coming
We're working on new analytics and tools. Stay tuned.
About
WATCH PART 2 NOW: http://bit.ly/1FtHIsg WATCH PART 3 NOW: http://bit.ly/1QtmosZ A drug called Truvada is the first the FDA approved means of preventing HIV infection. If an HIV-negative person takes the pill every day, they're nearly 99% protected from contracting the virus. Controversy continues to surround the broad…
- Published
- June 3, 2015
- Made for kids
- No
More features coming
We're working on new analytics and tools. Stay tuned.
Frequently asked questions
How accurate are these YouTube video analytics?
View, like, and comment counts come from YouTube's public API and refresh regularly. Growth and revenue figures are estimates built from tracked historical data, so they can differ slightly from what the creator sees privately in YouTube Studio.
What is the outlier score?
How this video's views compare to the channel's usual Shorts or long-form video. A 2x score means double the usual views for that channel, 0.5x means half.
What is engagement rate and how is it calculated?
Likes and comments per view, compared to this channel's typical engagement rate — shown as above or below what's usual for the channel.
How is the revenue estimate calculated?
It's a rough public estimate based on a $0.7–$2.0 CPM (revenue per 1,000 views) applied to view count — not actual creator earnings, which depend on ad rates, audience geography, and monetization settings YouTube doesn't expose publicly.
Is this YouTube video analytics checker free?
Yes. You get 10 free channel and video analytics lookups per rolling hour without an account — logging in, which is also free, removes that limit entirely.